Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys

The link between taking Zantac and developing certain types of cancer is being thoroughly examined

Thursday, March 31, 2022 - More than 125,000 who took Zantac, heartburn, and acid reflux medicine regularly and for more than a year have developed certain types of cancer and have registered to file a Zantac lawsuit. Studies indicate that ranitidine, the active ingredient in Zantac, is an inherently unstable molecule and degrades when overheated into N-nitrosodimethylamine (NDMA), a proven carcinogen. Zantac lawsuits are organized into multidistrict litigation (MDL) under one judge who makes administrative decisions to streamline the proceedings and avoid repeating certain procedures thousands of times. Each case will take place in the state where the individual filed the lawsuit. The first cases will be selected by the judge to represent the diversity of the plaintiff's pool and will begin in 2023. The outcomes of these bellwether cases will be analyzed and could result in the defendants Sanofi and Chevron making a settlement offer. One recent mass-tort lawsuit in MDL that resulted in a large settlement offer was when German pharmaceutical giant Bayer was held responsible for the wrongdoings of Monsanto, which they purchased in 2018. Over 125,000 Individuals alleged that using Roundup herbicide caused non-Hodgkin's lymphoma, a rare and deadly variation of cancer of the lymph nodes. After several trials where plaintiffs won hundreds of millions of dollars each, Bayer decided that the scientific evidence against them was too strong and the number of plaintiffs too daunting to attempt to defend themselves one by one, and Bayer settled for around $12 billion. Legal experts believe that the Zantac ranitidine litigation could surpass both the number of registered plaintiffs and the amount that Sanofi and Chevron will be forced to pay. Individuals that have received a cancer diagnosis having taken Zantac should speak with a heartburn medicine cancer lawyer to see if they qualify to join those seeking lump-sum monetary compensations. The judge in the Zantac MDL has isolated five types of cancer as being potentially related to taking Zantac. They are cancer of the bladder, esophagus, liver, pancreas and stomach.

At the core of the many benefits of multidistrict litigation is that the presiding MDL judge has the opportunity to interview scientific experts that both sides intend to call to weed out those whose testimony may be inflammatory or scientifically unsound. The judge intends to approve only two or three witnesses for each side that will be allowed to give testimony. The Zantac MDL judge is currently interviewing scientists. According to lawsuit-information-center.com, "The Magistrate Judge in the Zantac MDL granted a motion by the defendants requesting approval of additional time to complete the depositions of five key expert witnesses for the plaintiffs. These are all causation witnesses. These are the witnesses that provide a connection between Zantac and the five types of cancer being pursued in Zantac class-action lawsuit." One key witness for plaintiffs is sure to be David Light, CEO of online prescription drug testing pharmacy Valisure Inc. Several years ago, Valisure tested ranitidine and found it to contain highly elevated levels of NDMA and immediately filed a citizen's petition with the FDA urging them to recall ranitidine which the agency did on April 1, 2020.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.